The immunohistochemical assessment verifies the reduction in principal renal injury markers, such as KIM-1 and TGF-β1, thereby emphasizing DNR’s capacity to protect against renal fibrosis and injury. This evidence concerns the gene TGFB1 and renal fibrosis.